Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Randomized Trial of Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for the Treatment of Oligometastatic Pancreatic Adenocarcinoma

NCT04975516 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT04975516
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04975516 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Randomized Trial of Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for the Treatment of Oligometastatic Pancreatic Adenocarcinoma
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Terminated
Start date
July 18, 2023
Completion date
November 15, 2025
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic pancreatic adenocarcinoma, oligometastatic pancreatic ductal adenocarcinoma, recurrent pancreatic adenocarcinoma, stage iv pancreatic cancer ajcc v8